Annual Drug Patent Expirations for GRALISE
Gralise is a drug marketed by Almatica and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for GRALISE.
This drug has twenty-three patent family members in nine countries.
The generic ingredient in GRALISE is gabapentin. Two suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
